Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-057703

Director sold 4,600 shares at $17.94 ($82,524)

  • Director acquired 10,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CHESS ROBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-22 Grant or award : show line 1 in the form +10,200 284,473 D
2021-09-22 Sale : show line 2 in the form −4,600 $17.94 $82,524 279,873 D
Open-market sales · 4,600 sh · avg $17.94 · $82,524

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-22 Grant or award : show line 3 in the form Stock Option +20,400 20,400 D
Loading xslF345X03/doc4.xml…